ORAMED PHARMACEUTICALS INC. - COM NEW (ORMP)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024: Q1 2024
Type / Class: Equity / COM NEW
Shares, excl. options Q1 2024: 5.2 M
Holdings value Q1 2024: $15.2 M
Value change Q1 2024: +$378 K
Grand Portfolio weight change Q1 2024: +0%
Number of holders: 48
Number of buys Q1 2024: 20
Number of sells Q1 2024: -23
Average buys Q1 2024 %: +0%
Average sells Q1 2024 %: 0%
CUSIP: 68403P203

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Period	Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2024 Q1	5.2 M	$15.2 M	+$378 K	7.88 K	24.2 K	$2.92	49
2023 Q4	5.09 M	$11.8 M	+$6.47 M	7.62 K	67.7 K	$2.31	54
2023 Q3	2.29 M	$5.99 M	-$131 K	17.7 K	37.6 K	$2.61	54
2023 Q2	2.27 M	$8.14 M	-$6.04 M	15.4 K	120 K	$3.58	50
2023 Q1	4.26 M	$9.28 M	-$8.24 M	45.1 K	69.1 K	$2.18	57
2022 Q4	3.56 M	$42.8 M	+$3.07 M	2.95 M	2.29 M	$12.03	70
2022 Q3	3.89 M	$25.2 M	-$13.8 M	424 K	694 K	$6.48	61
2022 Q2	6.33 M	$28.6 M	-$18.7 M	135 K	572 K	$4.58	77
2022 Q1	8.23 M	$71.3 M	-$2.03 M	770 K	1.76 M	$8.65	91
2021 Q4	8.17 M	$117 M	+$37.3 M	2.28 M	4.67 M	$14.28	114
2021 Q3	5.41 M	$119 M	+$35.3 M	3.5 M	8.15 M	$21.98	90
2021 Q2	3.83 M	$51.3 M	+$35.1 M	839 K	2.41 M	$13.38	72
2021 Q1	1.24 M	$12.6 M	+$791 K	600 K	1.96 M	$10.16	44
2020 Q4	1.46 M	$6.17 M	-$1.61 M	65 K	299 K	$4.24	37
2020 Q3	2 M	$5.18 M	+$1.67 M		61 K	$2.61	33
2020 Q2	1.34 M	$4.69 M	+$2.53 M		345 K	$3.52	31
2020 Q1	611 K	$1.86 M	-$113 K	0	378 K	$3.04	27
2019 Q4	624 K	$3.22 M	-$405 K	91 K	561 K	$5.14	31
2019 Q3	753 K	$2.4 M	-$269 K			$3.19	25
2019 Q2	837 K	$3 M	-$844 K			$3.59	25
2019 Q1	1.07 M	$3.9 M	-$2.62 M			$3.64	24
2018 Q4	1.9 M	$5.69 M	+$414 K			$3.00	22
2018 Q3	1.71 M	$8.3 M	+$7.17 M			$4.86	25
2018 Q2	234 K	$1.74 M	+$40.3 K			$7.44	19
2018 Q1	256 K	$1.67 M	-$818 K			$6.51	19
2017 Q4	377 K	$3.4 M	+$788 K			$9.00	25
2017 Q3	275 K	$2.73 M	+$1.16 M			$9.92	22
2017 Q2	144 K	$1.12 M	+$276 K			$7.78	20
2017 Q1	142 K	$870 K	+$43 K			$6.12	18
2016 Q4	136 K	$832 K	-$375 K		0	$6.08	22
2016 Q3	178 K	$1.29 M	-$252 K	0	533 K	$7.26	20
2016 Q2	210 K	$1.75 M	+$546 K	98 K	907 K	$8.34	24
2016 Q1	100	$1 K	-$130 K	135 K	264 K	$6.65	2
2015 Q4	196 K	$1.66 M	+$387 K	153 K	349 K	$8.55	23
2015 Q3	156 K	$849 K	-$981 K	0	130 K	$5.47	16
2015 Q2	197	$2 K	+$1 K	111 K	385 K	$5.69	4
2015 Q1	100	$1 K	-$5 K	88 K		$8.19	2
2014 Q4	1.12 K	$6 K	-$155 K			$5.33	4
2014 Q3	586 K	$4.76 M	-$424 K	223 K	0	$8.08	17
2014 Q2	637 K	$6.13 M	+$928 K	505 K	127 K	$9.62	21
2014 Q1	522 K	$6.14 M	+$5.08 M		1 K	$11.79	20